Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Tuberculosis | Research

Anemia and opportunistic infections in hospitalized people living with HIV: a retrospective study

Authors: Bo Xie, Wei Huang, Yanling Hu, Yanyun Dou, Luman Xie, Yong Zhang, Shanfang Qin, Ke Lan, Xianwu Pang, Hong Qiu, Lanxiang Li, Xihua Wei, Zengjing Liu, Zhihao Meng, Jiannan Lv

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

There is a high prevalence of anemia among people living with HIV in Guangxi, China. Therefore, we investigated anemia and opportunistic infections in hospitalized people living with HIV and explored the risk factors related to anemia in people living with HIV to actively prevent anemia in people living with HIV.

Methods

We retrospectively studied people living with HIV admitted to Guangxi Chest Hospital from June 2016 to October 2021. Detailed information on the sociodemographic and clinical features of the participants was collected. The X2 test was used to compare the prevalence between the anemic and non-anemic groups. The logistic regression analysis was applied to exclude confounding factors and identify factors related to anemia.

Results

Among 5645 patients with HIV, 1525 (27.02%) had anemia. The overall prevalence of mild, moderate, and severe anemia was 4.66%, 14.08%, and 8.27%, respectively. The factors significantly related to increased risk of anemia were CD4 count < 50 cells/µl (aOR = 2.221, 95% CI = [1.775, 2.779]), CD4 count 50–199 cells/µl (aOR = 1.659, 95% CI = [1.327, 2. 073]), female (aOR = 1.644, 95% CI = [1.436, 1.881]) co-infected with HCV (aOR = 1.465, 95% CI = [1.071, 2.002]), PM (aOR = 2.356, 95% CI = [1.950, 2.849]), or TB (aOR = 1.198, 95% CI = [1.053, 1.365]).

Conclusions

Within Guangxi of China, 27.02% of hospitalized people living with HIV presented with anemia. Most patients with anemia were in the mild to moderate stage. The low CD4 count, female gender, and concomitant infection with Penicillium marneffei, Hepatitis C virus, or Tuberculosis were independent correlates of anemia. Thus, these findings would be helpful to clinicians in preventing and intervening in anemia in people living with HIV.
Literature
1.
go back to reference Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disord. 2009;13(9):5. Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disord. 2009;13(9):5.
2.
go back to reference Wankah PN, Tagny CT, Mbanya DN. Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, Cameroon. BMC Hematol. 2014;14(1):15.CrossRef Wankah PN, Tagny CT, Mbanya DN. Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, Cameroon. BMC Hematol. 2014;14(1):15.CrossRef
3.
go back to reference Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;38(10):1454–63.CrossRef Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;38(10):1454–63.CrossRef
4.
go back to reference Moore RD. Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy. Semin Hematol. 2000;37(4 Suppl 6):18–23.CrossRef Moore RD. Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy. Semin Hematol. 2000;37(4 Suppl 6):18–23.CrossRef
5.
go back to reference Semba RD. Iron-deficiency anemia and the cycle of poverty among human immunodeficiency virus-infected women in the inner city. Clin Infect Dis. 2003;37(Suppl 2):S105–11.CrossRef Semba RD. Iron-deficiency anemia and the cycle of poverty among human immunodeficiency virus-infected women in the inner city. Clin Infect Dis. 2003;37(Suppl 2):S105–11.CrossRef
6.
go back to reference Sullivan PS, Hanson DL, Chu SY, et al. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998;91(1):301–8.CrossRef Sullivan PS, Hanson DL, Chu SY, et al. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998;91(1):301–8.CrossRef
7.
go back to reference Assefa M, Abegaz WE, Shewamare A, et al. Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital. Ethiopia BMC Hematol. 2015;15:6.CrossRef Assefa M, Abegaz WE, Shewamare A, et al. Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital. Ethiopia BMC Hematol. 2015;15:6.CrossRef
8.
go back to reference Santiago-Rodriguez EJ, Mayor AM, Fernandez-Santos DM, et al. anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Res Notes. 2014;7:439.CrossRef Santiago-Rodriguez EJ, Mayor AM, Fernandez-Santos DM, et al. anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Res Notes. 2014;7:439.CrossRef
9.
go back to reference Breitbart W, McDonald MV, Rosenfeld B, et al. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage. 1998;15(3):159–67.CrossRef Breitbart W, McDonald MV, Rosenfeld B, et al. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage. 1998;15(3):159–67.CrossRef
10.
go back to reference Sudfeld CR, Kaaya S, Gunaratna NS, et al. Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV. AIDS. 2017;31(2):263–71.CrossRef Sudfeld CR, Kaaya S, Gunaratna NS, et al. Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV. AIDS. 2017;31(2):263–71.CrossRef
11.
go back to reference Dai G, Xiao J, Gao G, et al. anemia in combined antiretroviral treatment-naive HIV-infected patients in China: a retrospective study of prevalence, risk factors, and mortality. Biosci Trends. 2017;10(6):445–53.CrossRef Dai G, Xiao J, Gao G, et al. anemia in combined antiretroviral treatment-naive HIV-infected patients in China: a retrospective study of prevalence, risk factors, and mortality. Biosci Trends. 2017;10(6):445–53.CrossRef
12.
go back to reference Lai JL, Chen YH, Liu YM, et al. Prevalence and risk factors of anemia in hospitalised HIV-infected patients in southeast China: a retrospective study. Epidemiol Infect. 2019;147: e81.CrossRef Lai JL, Chen YH, Liu YM, et al. Prevalence and risk factors of anemia in hospitalised HIV-infected patients in southeast China: a retrospective study. Epidemiol Infect. 2019;147: e81.CrossRef
13.
go back to reference Shen Y, Wang Z, Lu H, Wang J, Chen J, Liu L, Zhang R, Zheng Y. Prevalence of anemia among adults with newly diagnosed HIV/AIDS in China. PLoS ONE. 2013;8(9): e73807.CrossRef Shen Y, Wang Z, Lu H, Wang J, Chen J, Liu L, Zhang R, Zheng Y. Prevalence of anemia among adults with newly diagnosed HIV/AIDS in China. PLoS ONE. 2013;8(9): e73807.CrossRef
14.
go back to reference Mijiti P, Yuexin Z, Min L, et al. Prevalence and predictors of anemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang. China Int J STD AIDS. 2015;26(3):156–64.CrossRef Mijiti P, Yuexin Z, Min L, et al. Prevalence and predictors of anemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang. China Int J STD AIDS. 2015;26(3):156–64.CrossRef
16.
go back to reference Piao JH, Lai JQ, Yin SA, et al. Study on anemia status of Chinese population (In Chinese). Acta Nutrimenta Sinica. 2005;27:268–71. Piao JH, Lai JQ, Yin SA, et al. Study on anemia status of Chinese population (In Chinese). Acta Nutrimenta Sinica. 2005;27:268–71.
17.
go back to reference Gedefaw L, Yemane T, Sahlemariam Z, et al. Anemia and risk factors in HAART naive and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS ONE. 2013;8(8): e72202.CrossRef Gedefaw L, Yemane T, Sahlemariam Z, et al. Anemia and risk factors in HAART naive and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS ONE. 2013;8(8): e72202.CrossRef
18.
go back to reference Dabrowska MM, Mikula T, Wiercinska-Drapalo A. The anemia prevalence and the association between complete blood count analysis and renal function parameters in HIV-1-infected patients. Curr HIV Res. 2012;10(3):247–51.CrossRef Dabrowska MM, Mikula T, Wiercinska-Drapalo A. The anemia prevalence and the association between complete blood count analysis and renal function parameters in HIV-1-infected patients. Curr HIV Res. 2012;10(3):247–51.CrossRef
19.
go back to reference Behler C, Shade S, Gregory K, et al. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses. 2005;21(3):200–6.CrossRef Behler C, Shade S, Gregory K, et al. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses. 2005;21(3):200–6.CrossRef
20.
go back to reference Xiao J, Han N, Yang D, et al. Lower mortality in persons infected with HIV receiving antiretroviral treatment in a hospital-based model: an observational cohort study. Future Virol. 2014;9(4):363–72.CrossRef Xiao J, Han N, Yang D, et al. Lower mortality in persons infected with HIV receiving antiretroviral treatment in a hospital-based model: an observational cohort study. Future Virol. 2014;9(4):363–72.CrossRef
21.
go back to reference Li HR, Cai SX, Chen YS, et al. Comparison of Talaromyces marneffei infection in human immunodeficiency virus-positive and human immunodeficiency virus-negative patients from Fujian, China. Chin Med J (Engl). 2016;129(9):1059–65.CrossRef Li HR, Cai SX, Chen YS, et al. Comparison of Talaromyces marneffei infection in human immunodeficiency virus-positive and human immunodeficiency virus-negative patients from Fujian, China. Chin Med J (Engl). 2016;129(9):1059–65.CrossRef
22.
go back to reference Subbaraman R, Devaleenal B, Selvamuthu P, et al. Factors associated with anemia in HIV-infected individuals in southern India. Int J STD AIDS. 2009;20(7):489–92.CrossRef Subbaraman R, Devaleenal B, Selvamuthu P, et al. Factors associated with anemia in HIV-infected individuals in southern India. Int J STD AIDS. 2009;20(7):489–92.CrossRef
23.
go back to reference Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23.CrossRef Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23.CrossRef
24.
go back to reference Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998;18(8):555–9.CrossRef Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998;18(8):555–9.CrossRef
25.
go back to reference Schwenk A, Macallan DC. Tuberculosis, malnutrition and wasting. Curr Opin Clin Nutr Metab Care. 2000;3(4):285–91.CrossRef Schwenk A, Macallan DC. Tuberculosis, malnutrition and wasting. Curr Opin Clin Nutr Metab Care. 2000;3(4):285–91.CrossRef
26.
go back to reference Dieterich DT. Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients. J Infect Dis. 2002;15(185 Suppl 2):S128–37.CrossRef Dieterich DT. Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients. J Infect Dis. 2002;15(185 Suppl 2):S128–37.CrossRef
27.
go back to reference Henry DH, Slim J, Lamarca A, et al. Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection. AIDS Res Hum Retroviruses. 2007;23(1):1–9.CrossRef Henry DH, Slim J, Lamarca A, et al. Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection. AIDS Res Hum Retroviruses. 2007;23(1):1–9.CrossRef
28.
go back to reference Buti M, Wong J, Casado MA, et al. Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients. J Hepatol. 2006;44(1 Suppl):S60–4.CrossRef Buti M, Wong J, Casado MA, et al. Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients. J Hepatol. 2006;44(1 Suppl):S60–4.CrossRef
29.
go back to reference Melese H, Wassie MM, Woldie H, et al. Anemia among adult HIV patients in Ethiopia: a hospital-based cross-sectional study. HIV AIDS (Auckl). 2017;9:25–30. Melese H, Wassie MM, Woldie H, et al. Anemia among adult HIV patients in Ethiopia: a hospital-based cross-sectional study. HIV AIDS (Auckl). 2017;9:25–30.
30.
go back to reference Moyle G. Anemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev. 2002;4(1):13–20. Moyle G. Anemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev. 2002;4(1):13–20.
31.
go back to reference Mugisha JO, Shafer LA, Van der Paal L, et al. Anemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Trop Med Int Health. 2008;13(6):788–94.CrossRef Mugisha JO, Shafer LA, Van der Paal L, et al. Anemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Trop Med Int Health. 2008;13(6):788–94.CrossRef
32.
go back to reference Wills TS, Nadler JP, Somboonwit C, et al. Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. AIDS Read. 2004;14(6):305–10 (313–5). Wills TS, Nadler JP, Somboonwit C, et al. Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. AIDS Read. 2004;14(6):305–10 (313–5).
33.
go back to reference Gibellini D, Clò A, Morini S, et al. Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol. 2013;2(2):91–101.CrossRef Gibellini D, Clò A, Morini S, et al. Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol. 2013;2(2):91–101.CrossRef
34.
go back to reference Ford N, Meintjes G, Vitoria M, et al. The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS. 2017;12(2):123–8.CrossRef Ford N, Meintjes G, Vitoria M, et al. The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS. 2017;12(2):123–8.CrossRef
35.
go back to reference Gascón P, Sathe SS, Rameshwar P. Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex. Am J Med. 1993;94(1):41–8.CrossRef Gascón P, Sathe SS, Rameshwar P. Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex. Am J Med. 1993;94(1):41–8.CrossRef
36.
go back to reference Harding BN, Whitney BM, Nance RM, et al. Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study. BMC Infect Dis. 2020;20(1):238.CrossRef Harding BN, Whitney BM, Nance RM, et al. Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study. BMC Infect Dis. 2020;20(1):238.CrossRef
37.
go back to reference Ferede G, Wondimeneh Y. Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematol. 2013;13(1):8.CrossRef Ferede G, Wondimeneh Y. Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematol. 2013;13(1):8.CrossRef
38.
go back to reference O’Connell C, Levine AM. Managing anemia in HIV-positive women. Womens Health (Lond). 2006;2(1):159–65.CrossRef O’Connell C, Levine AM. Managing anemia in HIV-positive women. Womens Health (Lond). 2006;2(1):159–65.CrossRef
39.
go back to reference Abioye AI, Andersen CT, Sudfeld CR, et al. Anemia, iron status, and HIV: a systematic review of the evidence. Adv Nutr. 2020;11(5):1334–63.CrossRef Abioye AI, Andersen CT, Sudfeld CR, et al. Anemia, iron status, and HIV: a systematic review of the evidence. Adv Nutr. 2020;11(5):1334–63.CrossRef
40.
go back to reference Castro L, Goldani LZ. Iron, folate and vitamin B12 parameters in HIV-1 infected patients with anaemia in southern Brazil. Trop Doct. 2009;39(2):83–5.CrossRef Castro L, Goldani LZ. Iron, folate and vitamin B12 parameters in HIV-1 infected patients with anaemia in southern Brazil. Trop Doct. 2009;39(2):83–5.CrossRef
Metadata
Title
Anemia and opportunistic infections in hospitalized people living with HIV: a retrospective study
Authors
Bo Xie
Wei Huang
Yanling Hu
Yanyun Dou
Luman Xie
Yong Zhang
Shanfang Qin
Ke Lan
Xianwu Pang
Hong Qiu
Lanxiang Li
Xihua Wei
Zengjing Liu
Zhihao Meng
Jiannan Lv
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07910-5

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.